We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
DFB Healthcare Acquisitions Corporation | NASDAQ:DFBHU | NASDAQ | Trust |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.05 | 9.54 | 199,999.99 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * Flynn James E | 2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) __X__ Other (specify below) *Director by Deputization |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/8/2019 | A(1) | 12400000 | A | $10.00 | 14900000 | I | Through Deerfield Private Design Fund IV, L.P. (2)(3) | ||
Common Stock | 11/8/2019 | J(4) | 652253 (4) | D | $0.00 (4) | 2279888 (4) | I | Through Deerfield/RAB Ventures, LLC (2)(3) | ||
Common Stock | 11/8/2019 | J(5) | 6087 | D | $0.00 (5) | 20000 | I | Through Deerfield Management Company, L.P. (2)(3)(6) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Private Placement Warrants | $11.50 | 11/8/2019 | J (4) | 460685 (4) | (7) | (7) | Common Stock | 460685 (4) | $0.00 (4) | 1640981 (4) | I | Through Deerfield/RAB Ventures, LLC (2)(3) | |||
Public Warrants | $11.50 | (8) | (8) | Common Stock | 833333 | 833333 | I | Through Deerfield Private Design Fund IV, L.P. (2)(3) |
Remarks: Steven Hochberg, a partner in Deerfield Management Company, served as a director of the Issuer until his resignation from the Issuer's board of directors immediately following the consummation of the Issuer's initial business combination. Following the transactions reported herein, the Issuer's common stock was reclassified as "Class A Common Stock." Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to Proteon Therapeutics, Inc. filed with the Securities and Exchange Commission on August 4, 2017 by Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., and James E. Flynn. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Flynn James E 780 THIRD AVENUE, 37TH FLOOR NEW YORK, NY 10017 | X | X | *Director by Deputization | ||
Deerfield Mgmt IV, L.P. 780 THIRD AVENUE, 37TH FLOOR NEW YORK, NY 10017 | X | X | * Director by Deputization | ||
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 780 THIRD AVENUE, 37TH FLOOR NEW YORK, NY 10017 | X | X | * Director by Deputization | ||
Deerfield Private Design Fund IV, L.P. 780 THIRD AVENUE 37TH FLOOR NEW YORK, NY 10017 | X | X | * Director by Deputization |
Signatures | ||
/s/ Jonathan Isler, Attorney-in-Fact | 11/13/2019 | |
**Signature of Reporting Person | Date |
1 Year DFB Healthcare Acquisiti... Chart |
1 Month DFB Healthcare Acquisiti... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions